The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA

Human Psychopharmacology

Volumn 27, Issue 2, 2012, Pages 167-176

  Wetherell, Mark A ^a,b   Atherton, Katie ^a   Grainger, Jessica ^a   Brosnan, Robert ^b   Scholey, Andrew B ^b  

^a NORTHUMBRIA UNIVERSITY   (United Kingdom)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

cannabis; MDMA; multitasking; perceived workload; stress reactivity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; DIETHYLAMINE; LYSERGIDE; RECREATIONAL DRUG;

ACUTE STRESS; ADULT; ALERTNESS; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL STRESS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; STIMULUS RESPONSE; WORKLOAD;

ADULT; AFFECT; AGE FACTORS; CANNABIS; FEMALE; HALLUCINOGENS; HUMANS; MALE; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS; WORKLOAD; YOUNG ADULT;

EID: 84858029269     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1261     Document Type: Article

References (40)

1. Bartholomew J, Holroyd S, Heffernan TM,. 2010. Does cannabis use affect prospective memory in young adults? J Psychopharmacol 24 (2): 241-246.
2. Bedi G, Redman J,. 2008. Ecstasy use and higher level cognitive functions: weak effects of ecstasy after control for potential confounds. Psychol Med 38 (9): 1319-1330.
3. Carroll B, Kathol R, Noyes R, Wald TG, Clamon GH,. 1993. Screening for depression and anxiety in cancer patients using the hospital anxiety and depression scale. Gen Hosp Psychiatry 15: 69-74. (Pubitemid 23118435)
4. Chida Y, Hamer M,. 2008. Chronic psychosocial factors and acute physiological responses to laboratory-induced stress in healthy populations: a quantitative review of 30years of investigation. Psychol Bull 134 (6): 829-885.
5. Cohen S, Kamarck T, Mermelstein R,. 1983. A global measure of perceived stress. J Health Soc Behav 24: 385-396.
6. Degenhardt L, Hall W,. (eds) 2010. The Health and Psychological Effects of "Ecstasy" (Mdma) Use. National Drug and Alcohol Research Centre: University of New South Wales, Sydney. NDARC Monograph No. 62.
7. Department of Health. United Kingdom drug situation: Annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2010.
8. Fernandez-Serrano MJ, Perez-Garcia M, Verdejo-Garcia A,. 2011. What are the specific vs. generalized effects of drug abuse on neuropsychological performance? Neurosci Biobehav Rev 35: 377-406.
9. Fisk JE, Montgomery C, Murphy P,. 2009. The association between the negative effects attributed to ecstasy use and measures of cognitive and mood among users. Hum Psychopharmacol Clin Exp 17 (5): 326-336.
10. Gonzalez R,. 2007. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychological Reviews 17: 347-361. (Pubitemid 47498179)
11. Hadjiefthyvoulou F, Fisk J, Montgomery C, Bridges N,. 2011. Prospective memory functioning among ecstasy / polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMT). Psychopharmacology 215 (4): 761-774.
12. Hart SG, Staveland LE,. 1988. Development of a multi-dimensional workload rating scale: Results of empirical and theoretical research., Hancock PA, Meshkati N,. (Eds.), In: Human Mental Workload. Amsterdam: Elsevier.
13. Hayatbakhsh MR, Najman JM, Jamrozik KD, Mamun AA, Alati R, Bor W,. 2007. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry 46: 408-417.
14. Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J,. 2001. Prospective memory, everyday cognitive failure and central executive function in recreational users of ecstasy. Hum Psychopharmacol Clin Exp 16 (8): 607-612. (Pubitemid 34036941)
15. Herbert J, Goodyer IM, Grossman AB, et al., 2006. Do corticosteroids damage the brain? J Neuroendocrinol 18: 393-411. (Pubitemid 43670845)
16. Lane SD, Cherek DR, Pietras CJ, Steinberg JL,. 2005. Performance of heavy marijuana-smoking adolescents on laboratory measure of motivation. Addic Behav 30: 815-828. (Pubitemid 40516846)
17. Lovell B, Moss M, Wetherell MA,. 2011. Perceived stress, common health complaints and diurnal patterns of cortisol secretion in young, otherwise healthy individuals. Horm Behav 60 (3): 301-305.
18. McCardle K, Luebbers JD, Carter JD, Croft RJ, Stough C,. 2004. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 173: 434-439. (Pubitemid 38703819)
19. Montgomery C, Hatton NP, Fisk JE, Ogden RS, Jansari A,. 2010. Assessing the functional significance of ecstasy-releated memory deficits using a virtual paradigm Human. Psychopharamcology 25: 318-325.
20. Murphy PM, Wareing M, Fisk JE, Montgomery C,. 2009. Executive working memory deficits in abstinent ecstasy / MDMA users: a critical review. Neuropsychobiology 60: 159-175.
21. Parrott AC,. 2006. MDMA in humans: factors which affect neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol 20 (2): 147-163.
22. Parrott AC,. 2009. Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal aspects of bioenergetic stress in ecstasy users. Neuropsychobiology 60: 148-158.
23. Parrott AC, Milani RM, Gouzoulis-Mayfrank E, Daumann J,. 2007. Cannabis and ecstasy / MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm 114: 959-968. (Pubitemid 47106452)
24. Parrott AC, Lock J, Conner A, Kissling C, Thome J,. 2008. Dance clubbing on MDMA and during abstinence from ecstasy / MDMA: prospective neuroendocrine and psychobiological changes. Neuropsychobiology 57: 165-180.
25. Reay JL, Hamilton C, Kennedy DO, Scholey AB,. 2006. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. J Psychopharmacol 20: 385-388.
26. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC,. 2001. Differential effects of ecstasy and cannabis on self-reports of memory ability: a web-based study. Hum Psychopharmacol Clin Exp 16 (8): 619-625. (Pubitemid 34036943)
27. Rodgers J, Buchanan T, Scholey AB, Heffernan T, Ling J, Parrott AC,. 2003. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study. J Psychopharmacol 17 (4): 389-396. (Pubitemid 38076333)
28. Rodgers J, Buchanan T, Pearson C, Parrott AC, Heffernan T, Scholey AB,. 2006. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study. J Psychopharmacol 20 (3): 437-446.
29. Saxbe DE,. 2008. A field (researcher's) guide to cortisol: tracking HPA axis functioning in everyday life. Health Psychology Review 2 (2): 163-190.
30. Schilt T, Koeter MWJ, Smal JP, Gouwetor MN, van den Brink W, Schmand B,. 2010. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users. Psychopharmacology 207: 583-591.
31. Scholey, AB, Owen, L, Gates, J, et al., 2011. Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory. Neuropsychobiology 63: 15-21.
32. Solowij N, Hall W, Lee N,. 1992. Recreational MDMA use in Sydney: a profile of ecstasy users and their experiences with the drug. Br J Addict 87: 1161-1172.
33. Solowij N,. 1998. Cannabis and Cognitive Functioning. Cambridge University Press: Cambridge.
34. Solowij N, Battisti R,. 2008. The chronic effects of cannabis on memory in humans: A review. Curr Drug Abuse Rev 1: 81-98.
35. Thomas H,. 1996. A community survey of adverse effects of cannabis use. Drug Alcohol Depend 42: 201-207. (Pubitemid 26356554)
36. Verheydeni SL, Henry JA, Curran V,. 2003. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Hum Psychopharmacol 18: 507-517. (Pubitemid 37279232)
37. Wadsworth EJK, Moss SC, Simpson SA, Smith AP,. 2006. Cannabis use, cognitive performance and mood in a sample of workers. J Psychopharmacol 20 (1): 14-23.
38. Wetherell MA, Sidgreaves MC,. 2005. Secretory Immunoglobulin A Reactivity Following Increases in Workload Intensity Using the Defined Intensity Stressor Simulation (DISS). Stress and Health 21: 99-106. (Pubitemid 40590486)
39. Zakzanis KK, Campbell Z, Jovanovski D,. 2007. The neuropsychology of ecstasy (MDMA) use: a quantitative review. Hum Psychopharmacol Clin Exp 22: 427-435. (Pubitemid 47611297)
40. Zigmond AS, Snaith RP,. 1983. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (6): 361-70. (Pubitemid 13098606)